Medicinal Plants for Managing Post-COVID-19 Complications
Keywords:
COVID-19, Complications, Mechanisms of action of Medicinal Plants, Medicinal HerbsAbstract
Post-COVID-19 syndrome symptoms include circulatory abnormalities, respiratory problems, mental health concerns, and chronic fatigue. The burden that these illnesses placed on the global healthcare system led to a rise in complementary and alternative medicine, particularly medicinal plant therapies. Medicinal plants have long been used in traditional medicine for their antiviral, immunomodulatory, antioxidant, and anti-inflammatory properties. These properties are currently being studied. By lowering oxidative damage, immune response modulation, and chronic inflammation, these compounds with bioactive properties could assist in lessening the long-term consequences of COVID-19. Additional clinical trials were needed to verify the safety and efficacy of these medicines, even though initial study results suggested that medicinal plants might aid COVID-19 patients in recovering and living longer. The article provides comprehensive medical strategies that consider the needs of patients post COVID-19. It is recommended to use evidence-based medicinal herbs in addition to traditional therapy
Downloads
References
B. Gallo Marin et al., "Predictors of COVID‐19 severity: a literature review," Reviews in medical virology, vol. 31, no. 1, pp. 1-10, 2021. DOI: https://doi.org/10.1002/rmv.2146.
Y. Shi et al., "An overview of COVID-19," (in eng), J Zhejiang Univ Sci B, vol. 21, no. 5, pp. 343-360, May 2020. doi: 10.1631/jzus.B2000083· PMID:PMC7205601.
A. Sharma, I. Ahmad Farouk, and S. K. Lal, "COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention," (in eng), Viruses, vol. 13, no. 2, Jan 29 2021. DOI: 10.3390/v13020202· PMID:PMC7911532.
D. Cucinotta and M. Vanelli, "WHO Declares COVID-19 a Pandemic," (in eng), Acta Biomed, vol. 91, no. 1, pp. 157-160, Mar 19 2020. DOI: 10.23750/abm.v91i1.9397· PMID:PMC7569573 stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.
Y. Chen, C. Zhang, and Y. Feng, "Medicinal Plants for the Management of Post-COVID-19 Fatigue: a Literature Review on the Role and Mechanisms," Journal of Traditional and Complementary Medicine, 2024.
H. Hozhabri et al., "The global emergency of novel coronavirus (SARS-CoV-2): An update of the current status and forecasting," International journal of environmental research and public health, vol. 17, no. 16, p. 5648, 2020.
C. Sonkar, V. Hase, D. Banerjee, A. Kumar, R. Kumar, and H. C. Jha, "Post COVID-19 complications, adjunct therapy explored, and steroidal after effects," Canadian Journal of Chemistry, vol. 100, no. 7, pp. 459-474, 2022. DOI: 10.1139/cjc-2021-0247.
H. Lowe, B. Steele, J. Bryant, E. Fouad, N. Toyang, and W. Ngwa, "Antiviral activity of Jamaican medicinal plants and isolated bioactive compounds," Molecules, vol. 26, no. 3, p. 607, 2021.
A. Sadeek and E. Abdallah, "Medicinal Plants with Antiviral Properties to Tackle Covid-19 Pandemic: A Short-Review," Antivirals, vol. 2, pp. 122-127, 2021.
J. Nawrot, J. Gornowicz-Porowska, J. Budzianowski, G. Nowak, G. Schroeder, and J. Kurczewska, "Medicinal herbs in the relief of neurological, cardiovascular, and respiratory symptoms after COVID-19 infection a literature review," Cells, vol. 11, no. 12, p. 1897, 2022.
P. K. Mukherjee et al., "Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications," Phytomedicine, vol. 98, p. 153930, 2022.
I. Al-Jahdhami, K. Al-Naamani, A. Al-Mawali, and S. M. Bennji, "Respiratory complications after COVID-19," Oman medical journal, vol. 37, no. 1, p. e343, 2022.
A. D. Desai, M. Lavelle, B. C. Boursiquot, and E. Y. Wan, "Long-term complications of COVID-19," (in eng), Am J Physiol Cell Physiol, vol. 322, no. 1, pp. C1-c11, Jan 1 2022. DOI: 10.1152/ajpcell.00375.2021· PMID:PMC8721906.
L. T. McDonald, "Healing after COVID-19: are survivors at risk for pulmonary fibrosis?," American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 320, no. 2, pp. L257-L265, 2021.
D. Wichmann et al., "Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study," Annals of internal medicine, vol. 173, no. 4, pp. 268-277, 2020.
N. England, After-care needs of inpatients recovering from COVID-19. NHS England, 2020.
A. Carfì, R. Bernabei, and F. Landi, "Persistent symptoms in patients after acute COVID-19," Jama, vol. 324, no. 6, pp. 603-605, 2020.
B. Sharma, "How does COVID-19 affect the heart," Hackensack Meridian Health, vol. 13, 2020.
V. O. Puntmann et al., "Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)," JAMA cardiology, vol. 5, no. 11, pp. 1265-1273, 2020.
T. Guo et al., "Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)," JAMA Cardiology, vol. 5, no. 7, pp. 811-818, 2020. DOI: 10.1001/jamacardio.2020.1017.
Y. Kang et al., "Cardiovascular manifestations and treatment considerations in COVID-19," Heart, vol. 106, no. 15, pp. 1132-1141, 2020.
O. Abdel-Mannan et al., "Neurologic and radiographic findings associated with COVID-19 infection in children," JAMA neurology, vol. 77, no. 11, pp. 1440-1445, 2020.
A. Nalbandian et al., "Post-acute COVID-19 syndrome," Nature medicine, vol. 27, no. 4, pp. 601-615, 2021.
A. D. Desai, M. Lavelle, B. C. Boursiquot, and E. Y. Wan, "Long-term complications of COVID-19," American Journal of Physiology-Cell Physiology, vol. 322, no. 1, pp. C1-C11, 2022.
K. N. Arca and A. J. Starling, "Treatment-refractory headache in the setting of COVID-19 pneumonia: migraine or meningoencephalitis? Case report," SN Comprehensive Clinical Medicine, vol. 2, pp. 1200-1203, 2020.
F. Asghar, N. Shamim, U. Farooque, H. Sheikh, and R. Aqeel, "Telogen effluvium: a review of the literature," Cureus, vol. 12, no. 5, 2020.
A. Esmaeilzadeh, R. Elahi, A. Siahmansouri, A. J. Maleki, and A. Moradi, "Endocrine and metabolic complications of COVID-19: lessons learned and future prospects," (in eng), J Mol Endocrinol, vol. 69, no. 3, pp. R125-r150, Oct 1 2022. DOI: 10.1530/jme-22-0036.
E. de-Madaria, K. Siau, and K. Cárdenas-Jaén, "Increased amylase and lipase in patients with COVID-19 pneumonia: don't blame the pancreas just yet!," Gastroenterology, vol. 160, no. 5, p. 1871, 2020.
B. Khoo et al., "Thyroid function before, during, and after COVID-19," The Journal of Clinical Endocrinology & Metabolism, vol. 106, no. 2, pp. e803-e811, 2021.
L. Ma et al., "Effect of SARS-CoV-2 infection upon male gonadal function: a single center-based study," MedRxiv, p. 2020.03. 21.20037267, 2020.
M. Mateu-Salat, E. Urgell, and A. Chico, "SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19," Journal of endocrinological investigation, vol. 43, pp. 1527-1528, 2020.
J. Joli, P. Buck, S. Zipfel, and A. Stengel, "Post-COVID-19 fatigue: A systematic review," Frontiers in psychiatry, vol. 13, p. 947973, 2022.
K. Poole-Wright, I. Guennouni, O. Sterry, R. A. Evans, F. Gaughran, and T. Chalder, "Fatigue outcomes following COVID-19: a systematic review and meta-analysis," (in eng), BMJ Open, vol. 13, no. 4, p. e063969, Apr 26 2023. doi: 10.1136/bmjopen-2022-063969· PMID:PMC10151247.
D. Basu, V. P. Chavda, and A. A. Mehta, "Therapeutics for COVID-19 and post COVID-19 complications: An update," Current Research in Pharmacology and Drug Discovery, vol. 3, p. 100086, 2022/01/01/ 2022. DOI: https://doi.org/10.1016/j.crphar.2022.100086.
F. Ceban et al., "Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis," Brain, behavior, and immunity, vol. 101, pp. 93-135, 2022.
P. Wostyn, "COVID-19 and chronic fatigue syndrome: Is the worst yet to come?," Medical hypotheses, vol. 146, p. 110469, 2021.
S. Yende and C. R. Parikh, "Long COVID and kidney disease," Nature Reviews Nephrology, vol. 17, no. 12, pp. 792-793, 2021.
S. Y. Robbins-Juarez et al., "Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and meta-analysis," Kidney international reports, vol. 5, no. 8, pp. 1149-1160, 2020.
D. Sharma, M. Joshi, S. Apparsundaram, R. K. Goyal, B. Patel, and M. Dhobi, "Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate," Molecular and Cellular Biochemistry, vol. 478, no. 10, pp. 2221-2240, 2023.
O. L. Aiyegbusi et al., "Symptoms, complications and management of long COVID: a review," Journal of the Royal Society of Medicine, vol. 114, no. 9, pp. 428-442, 2021.
Q. Cai et al., "Obesity and COVID-19 severity in a designated hospital in Shenzhen, China," Diabetes care, vol. 43, no. 7, pp. 1392-1398, 2020.
D. Chen et al., "Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19)," MedRxiv, p. 2020.02. 27.20028530, 2020.
T. Zuo et al., "Alterations in gut microbiota of patients with COVID-19 during time of hospitalization," Gastroenterology, vol. 159, no. 3, pp. 944-955. e8, 2020.
D. Kanmaniraja et al., "Review of COVID-19, part 1: abdominal manifestations in adults and multisystem inflammatory syndrome in children," Clinical Imaging, vol. 80, pp. 88-110, 2021.
Y.-W. An et al., "Liver function recovery of COVID-19 patients after discharge, a follow-up study," International journal of medical sciences, vol. 18, no. 1, p. 176, 2021.
B. A. Cayón Figueroa, W. Mendoza Rojas, and D. Tiburcio Jiménez, "Dermatological complications due to post‑COVID‑19 syndrome: A systematic review," Medicine International, vol. 5, no. 1, p. 9, 2024.
F. N. Mirza, A. A. Malik, S. B. Omer, and A. Sethi, "Dermatologic manifestations of COVID‐19: a comprehensive systematic review," International Journal of Dermatology, vol. 60, no. 4, pp. 418-450, 2021.
C. Huang et al., "RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study," The lancet, vol. 397, no. 10270, pp. 220-232, 2021.
R. A. Dar, M. Shahnawaz, and P. H. Qazi, "General overview of medicinal plants: A review," The journal of phytopharmacology, vol. 6, no. 6, pp. 349-351, 2017.
A. C. Silveira Rabelo and D. Caldeira Costa, "A review of biological and pharmacological activities of Baccharis trimera," Chemico-Biological Interactions, vol. 296, pp. 65-75, 2018/12/25/ 2018. DOI: https://doi.org/10.1016/j.cbi.2018.09.002.
J. Maldonado Miranda, "Medicinal plants and their traditional uses in different locations," Phytomedicine, pp. 207-223, 2021.
B. Salehi et al., "Plant-food-derived bioactives: Key health benefits and current nanosystems as a strategy to enhance their bioavailability," Cellular and Molecular Biology, vol. 66, no. 4, pp. 232-242, 2020.
J. J. M. Miranda, "Medicinal plants and their traditional uses in different locations," in Phytomedicine: Elsevier, 2021, pp. 207-223.
O. Oladeji, "The characteristics and roles of medicinal plants: Some important medicinal plants in Nigeria," Natural Products: An Indian Journal, vol. 12, no. 3, p. 102, 2016.
V. Patel and R. Patel, "The active constituents of herbs and their plant chemistry, extraction and identification methods," Journal of chemical and pharmaceutical research, vol. 8, no. 4, pp. 1423-1443, 2016.
C. Sharanya, A. Sabu, and M. Haridas, "Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review," Future Journal of Pharmaceutical Sciences, vol. 7, no. 1, p. 113, 2021.
J. D. Gbenou et al., "Traditional medicinal plants used in the treatment of viral diseases," Advances in Traditional Medicine, vol. 24, no. 1, pp. 99-131, 2024.
L. Subudhi, H. Thatoi, and A. Banerjee, "Anti-inflammatory activity of essential oil from medicinal plants: An insight into molecular mechanism, in-silico studies and signaling pathways," Phytomedicine, p. 156364, 2025/01/02/ 2025. DOI: https://doi.org/10.1016/j.phymed.2025.156364.
T. L. Freeman and T. H. Swartz, "Targeting the NLRP3 Inflammasome in Severe COVID-19," (in eng), Front Immunol, vol. 11, p. 1518, 2020. DOI: 10.3389/fimmu.2020.01518· PMID:PMC7324760.
C. S. Nworu and P. A. Akah, "Anti-inflammatory medicinal plants and the molecular mechanisms underlying their activities," African Journal of Traditional, Complementary and Alternative Medicines, vol. 12, pp. 52-61, 2015.
M. V. Suresh et al., "Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury," American journal of respiratory cell and molecular biology, vol. 47, no. 3, pp. 280-287, 2012.
M. R. Khazdair, S. Ghafari, and M. Sadeghi, "Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19," Pharmaceutical biology, vol. 59, no. 1, pp. 694-701, 2021.
A. T. Utami and A. G. A. Qarrah, "Benefi ts of Ginger as Medicine for COVID-19: Literature Study," Journal ISSN, vol. 2766, p. 2276, 2022.
A. Saeedi-Boroujeni and M.-R. Mahmoudian-Sani, "Anti-inflammatory potential of Quercetin in COVID-19 treatment," Journal of Inflammation, vol. 18, pp. 1-9, 2021.
M. K. Shukla et al., "Potential immunomodulatory activities of plant products," South African Journal of Botany, vol. 149, pp. 937-943, 2022.
A. S. Shah, M. A. Gunjal, and A. R. Juvekar, "Immunomostimulatory activity of aqueous extract of Azadirachta indica flowers on specific and non specific immune response," Journal of Natural remedies, pp. 35-42, 2009.
D. Gautam, K. Regmi, S. Shrestha, and P. Karki, "Medicinal Plants as A Natural Immunity Booster Against Covid 19: A Review," Kalika Journal of Multidisciplinary Studies, vol. 6, no. 1, pp. 145-167, 2024.
D. Sharma, M. Joshi, S. Apparsundaram, R. K. Goyal, B. Patel, and M. Dhobi, "Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate," (in eng), Mol Cell Biochem, vol. 478, no. 10, pp. 2221-2240, Oct 2023. DOI: 10.1007/s11010-022-04654-3· PMID:PMC9868520.
A. Ganeshpurkar and A. K. Saluja, "Immunomodulatory effect of rutin, catechin, and hesperidin on macrophage function," Indian Journal of Biochemistry and Biophysics, 2020.
N. M. P. Maideen, "Prophetic Medicine-Nigella Sativa (Black cumin seeds) - Potential herb for COVID-19?," (in eng), J Pharmacopuncture, vol. 23, no. 2, pp. 62-70, Jun 30 2020. DOI: 10.3831/kpi.2020.23.010· PMID:PMC7338708.
M. F. Orozco, A. Vázquez-Hernández, and B. Fenton-Navarro, "Active compounds of medicinal plants, mechanism for antioxidant and beneficial effects," 2019.
S. Škrovánková, L. Mišurcová, and L. Machů, "Chapter Three - Antioxidant Activity and Protecting Health Effects of Common Medicinal Plants," in Advances in Food and Nutrition Research, vol. 67, J. Henry, Ed.: Academic Press, 2012, pp. 75-139.
S. Tanweer, T. Mehmood, S. Zainab, Z. Ahmad, and A. Shehzad, "Comparison and HPLC quantification of antioxidant profiling of ginger rhizome, leaves and flower extracts," Clinical Phytoscience, vol. 6, pp. 1-12, 2020.
R. Cecchini and A. L. Cecchini, "SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression," Medical hypotheses, vol. 143, p. 110102, 2020.
A. Mirzaie, M. Halaji, F. S. Dehkordi, R. Ranjbar, and H. Noorbazargan, "A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19)," Complementary therapies in clinical practice, vol. 40, p. 101214, 2020.
J. G. Choi, Y. S. Kim, J. H. Kim, and H. S. Chung, "Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition," (in eng), Sci Rep, vol. 9, no. 1, p. 12132, Aug 20 2019. DOI: 10.1038/s41598-019-48430-8· PMID:PMC6702199.
R. Bhattacharya, K. Dev, and A. Sourirajan, "Antiviral activity of bioactive phytocompounds against coronavirus: An update," Journal of Virological Methods, vol. 290, p. 114070, 2021.
A. E. Al-Snafi, "Medicinal plants with antiviral effect: A review," GSC Biological and Pharmaceutical Sciences, vol. 24, no. 1, pp. 098-113, 2023.
S. Jo, H. Kim, S. Kim, D. H. Shin, and M. S. Kim, "Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors," Chemical biology & drug design, vol. 94, no. 6, pp. 2023-2030, 2019.
M. A. Beck, Q. Shi, V. C. Morris, and O. A. Levander, "Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates," Nature medicine, vol. 1, no. 5, pp. 433-436, 1995.
R. Rolta, D. Salaria, V. Kumar, A. Sourirajan, and K. Dev, "Phytocompounds of Rheum emodi, Thymus serpyllum and Artemisia annua inhibit COVID-19 binding to ACE2 receptor: in silico approach. Curr Pharmacol Rep. 2021," This In silico study showed that artemisinin stably interact with SARS-CoV-2 spike glycoproteins (6VXX and 6VYB), hence proposed as a potential phytochemical to prevent SARS-CoV-2 interaction with ACE-2 receptor.
T. Khan, M. A. Khan, Z. U. Mashwani, N. Ullah, and A. Nadhman, "Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites," (in eng), Biocatal Agric Biotechnol, vol. 31, p. 101890, Jan 2021. DOI: 10.1016/j.bcab.2020.101890· PMID:PMC7831775.
Q. M. S. Jamal, "Antiviral Potential of Plants against COVID-19 during Outbreaks-An Update," (in eng), Int J Mol Sci, vol. 23, no. 21, Nov 5 2022. DOI: 10.3390/ijms232113564· PMID:PMC9655040.
P. Jakubec, K. Fišerová, S. Genzor, and M. Kolář, "Pulmonary Complications after COVID-19," (in eng), Life (Basel), vol. 12, no. 3, Feb 28 2022. DOI: 10.3390/life12030357· PMID:PMC8955291.
Y.-Q. He et al., "Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms," Pharmacological Research, vol. 163, p. 105224, 2021/01/01/ 2021. DOI: https://doi.org/10.1016/j.phrs.2020.105224.
M. F. Jubayer et al., "Therapeutic potential of selective medicinal plants and their phytoconstituents in respiratory diseases: A review with an emphasis on COVID-19."
Y.-C. Yeh et al., "Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) suppress SARS-CoV-2 entry and COVID-19 related cytokine storm in vitro," Frontiers in pharmacology, vol. 12, p. 765553, 2022.
M. B. Oppong, L. Yang, P. O. Banahene, F. Shi-Ming, and Q. Feng, "Ethnopharmacology, phytochemistry, and pharmacology of Sterculia lychnophora Hance (Pangdahai)," Chinese journal of natural medicines, vol. 16, no. 10, pp. 721-731, 2018.
A. Ghosh et al., "Nutraceutical prospects of Houttuynia cordata against the infectious viruses," Food Bioscience, vol. 50, p. 101977, 2022.
B. Joh, E. S. Jeon, S. H. Lim, Y. L. Park, W. Park, and H. Chae, "Intercultural usage of Mori Folium: comparison review from a Korean medical perspective," Evidence‐Based Complementary and Alternative Medicine, vol. 2015, no. 1, p. 379268, 2015.
A. Sieben et al., "α-Hederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behavior, dynamics, and regulation of β2-adrenergic receptors," Biochemistry, vol. 48, no. 15, pp. 3477-3482, 2009.
S. M. Thota, V. Balan, and V. Sivaramakrishnan, "Natural products as home‐based prophylactic and symptom management agents in the setting of COVID‐19," Phytotherapy Research, vol. 34, no. 12, pp. 3148-3167, 2020.
L. Fan and X. Ding, "Potential Effects of Traditional Chinese Medicine on COVID-19 and Cardiac Injury: Mechanisms and Clinical Evidence," Journal of Multidisciplinary Healthcare, pp. 2863-2872, 2023.
B. Baharvand-Ahmadi, M. Bahmani, Z. Eftekhari, M. Jelodari, and M. Mirhoseini, "Overview of medicinal plants used for cardiovascular system disorders and diseases in ethnobotany of different areas in Iran," Journal of HerbMed Pharmacology, vol. 5, no. 1, pp. 39-44, 2015.
S. Rastogi, D. N. Pandey, and R. H. Singh, "COVID-19 pandemic: A pragmatic plan for ayurveda intervention," Journal of Ayurveda and Integrative medicine, vol. 13, no. 1, p. 100312, 2022.
K. Khanna et al., "Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle," Phytomedicine, vol. 85, p. 153361, 2021.
R. Kaur, H. Kaur, and A. S. Dhindsa, "Glycyrrhiza glabra: a phytopharmacological review," International journal of pharmaceutical Sciences and Research, vol. 4, no. 7, p. 2470, 2013.
D. Wang et al., "Cardiovascular protective effect of black pepper (Piper nigrum L.) and its major bioactive constituent piperine," Trends in Food Science & Technology, vol. 117, pp. 34-45, 2021.
K. Saki et al., "The most common native medicinal plants used for psychiatric and neurological disorders in Urmia city, northwest of Iran," Asian Pacific Journal of Tropical Disease, vol. 4, pp. S895-S901, 2014.
C. Y. J. Ng, H. H. Bun, Y. Zhao, and L. L. Zhong, "TCM “medicine and food homology” in the management of post-COVID disorders," Frontiers in Immunology, vol. 14, p. 1234307, 2023.
A. K. Ruíz-Salinas et al., "The treatment of Goji berry (Lycium barbarum) improves the neuroplasticity of the prefrontal cortex and hippocampus in aged rats," The Journal of Nutritional Biochemistry, vol. 83, p. 108416, 2020.
P. Xu et al., "Protective effect of lavender oil on scopolamine induced cognitive deficits in mice and H2O2 induced cytotoxicity in PC12 cells," Journal of ethnopharmacology, vol. 193, pp. 408-415, 2016.
K. Ma et al., "From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors," Biomedicine & pharmacotherapy, vol. 132, p. 110810, 2020.
J. Tian, S. Qin, J. Han, J. Meng, and A. Liang, "A review of the ethnopharmacology, phytochemistry, pharmacology and toxicology of Fructus Gardeniae (Zhi-zi)," Journal of Ethnopharmacology, vol. 289, p. 114984, 2022.
Y. Lai et al., "Clinical and economic analysis of Gastrodin injection for dizziness or vertigo: a retrospective cohort study based on electronic health records in China," Chinese Medicine, vol. 17, no. 1, p. 6, 2022.
S. Singh and A. Khan, "Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study," Gastroenterology, vol. 159, no. 2, pp. 768-771. e3, 2020.
R. W. Mwangi, J. M. Macharia, I. N. Wagara, and R. L. Bence, "The medicinal properties of Cassia fistula L: A review," Biomedicine & Pharmacotherapy, vol. 144, p. 112240, 2021.
F. Rafieian, R. Amani, A. Rezaei, A. C. Karaça, and S. M. Jafari, "Exploring fennel (Foeniculum vulgare): Composition, functional properties, potential health benefits, and safety," Critical Reviews in Food Science and Nutrition, vol. 64, no. 20, pp. 6924-6941, 2024.
B. Abbott, "US coronavirus patients with other conditions hospitalized at higher rates," The Wall Street Journal, 2020.
E. Yarnell and K. Abascal, "Herbs for relieving chronic renal failure," Alternative & Complementary Therapies, vol. 13, no. 1, pp. 18-23, 2007.
Y. Yang, M. Ye-ping, Z. Zhang, D. Pei-lin, P. Li, and L. Wen-ge, "Effects of adding Rheum officinale to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal function in patients with chronic renal failure: A meta-analysis of randomized controlled trials," Clinical Nephrology, vol. 89, no. 6, p. 445, 2018.
L. Rezagholizadeh, M. Aghamohammadian, M. Oloumi, S. Banaei, M. Mazani, and M. Ojarudi, "Inhibitory effects of Ficus carica and Olea europaea on pro-inflammatory cytokines: A review," Iranian Journal of Basic Medical Sciences, vol. 25, no. 3, p. 268, 2022.
Y. Qiao et al., "Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation," Toxicology letters, vol. 284, pp. 37-45, 2018.
L. Yao, "Quercetin, inflammation and immunity," 2016.
Y. Chen, C. Zhang, and Y. Feng, "Medicinal plants for the management of post-COVID-19 fatigue: A literature review on the role and mechanisms," Journal of Traditional and Complementary Medicine, vol. 15, no. 1, pp. 15-23, 2025/01/01/ 2025. DOI: https://doi.org/10.1016/j.jtcme.2024.05.006.
S. Patel, V. Sharma, N. S Chauhan, M. Thakur, and V. K. Dixit, "Hair growth: focus on herbal therapeutic agent," Current drug discovery technologies, vol. 12, no. 1, pp. 21-42, 2015.
A. Sinadinos and J. Shelswell, "Oral ulceration and blistering in patients with COVID-19," Evidence-based dentistry, vol. 21, no. 2, pp. 49-49, 2020.
X.-P. Gong, Y. Tang, Y.-Y. Song, G. Du, and J. Li, "Comprehensive review of phytochemical constituents, pharmacological properties, and clinical applications of Prunus mume," Frontiers in Pharmacology, vol. 12, p. 679378, 2021.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Basrah Researches Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
